Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study

被引:16
作者
Rovida, Francesca [1 ]
Cassaniti, Irene [1 ]
Percivalle, Elena [1 ]
Sarasini, Antonella [1 ]
Paolucci, Stefania [1 ]
Klersy, Catherine [2 ]
Cutti, Sara [3 ]
Novelli, Viola [3 ]
Marena, Carlo [3 ]
Luzzaro, Francesco [4 ]
De Vito, Giovanni [5 ]
Schiavo, Roberta [6 ]
Lo Cascio, Giuliana [6 ]
Lilleri, Daniele [1 ]
Baldanti, Fausto [1 ,7 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, I-27100 Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Biometry & Clin Epidemiol Serv, Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Med Direct, Pavia, Italy
[4] Lecco A Manzoni Hosp, Clin Microbiol & Virol Unit, Lecce, Italy
[5] Milano Bicocca Univ, A Manzoni Hosp, Sch Med & Surg, Occupat Med Unit, Lecce, Italy
[6] Guglielmo da Saliceto Hosp, Clin Pathol Dept, Microbiol Unit, Piacenza, Italy
[7] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy
基金
欧盟地平线“2020”;
关键词
SARS-CoV-2; infection; secondary infection; neutralizing antibody; immune protection;
D O I
10.1016/j.ijid.2021.07.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The protection from SARS-CoV-2 infection induced by SARS-CoV-2 anti-S1 and anti-S2 IgG antibody positivity resulting from natural infection was evaluated. Methods: The frequency of SARS-CoV-2 infection (as determined by virus RNA detection) was evaluated in a group of 1,460 seropositive and a control group of 8,150 seronegative healthcare workers in three Centres of Northern Italy in the period June-November 2020. Neutralizing serum titers were analyzed in seropositive subjects with or without secondary SARS-CoV-2 infection. Results: During the 6-month survey, 1.78% seropositive subjects developed secondary SARS-CoV-2 infection while 6.63% seronegative controls developed primary infection (odds ratio: 0.26; 95% confidence interval: 0.17-0.38). Secondary infection was associated with low or absent serum neutralizing titer (p < 0.01) and was mildly symptomatic in 45.8% cases vs 71.4% symptomatic primary infections (odds ratio: 0.34; 95% confidence interval: 0.16-0.78). Conclusions: Immunity from natural infection appears protective from secondary infection; therefore, vaccination of seronegative subjects might be prioritized. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:199 / 202
页数:4
相关论文
共 14 条
[1]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[2]  
European Centre for Disease Prevention and Control, 2021, REINF SARS COV 2 IMP
[3]   Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals [J].
Grifoni, Alba ;
Weiskopf, Daniela ;
Ramirez, Sydney, I ;
Mateus, Jose ;
Dan, Jennifer M. ;
Moderbacher, Carolyn Rydyznski ;
Rawlings, Stephen A. ;
Sutherland, Aaron ;
Premkumar, Lakshmanane ;
Jadi, Ramesh S. ;
Marrama, Daniel ;
de Silva, Aravinda M. ;
Frazier, April ;
Carlin, Aaron F. ;
Greenbaum, Jason A. ;
Peters, Bjoern ;
Krammer, Florian ;
Smith, Davey M. ;
Crotty, Shane ;
Sette, Alessandro .
CELL, 2020, 181 (07) :1489-+
[4]   SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) [J].
Hall, Victoria Jane ;
Foulkes, Sarah ;
Charlett, Andre ;
Atti, Ana ;
Monk, Edward J. M. ;
Simmons, Ruth ;
Wellington, Edgar ;
Cole, Michelle J. ;
Saei, Ayoub ;
Oguti, Blanche ;
Munro, Katie ;
Wallace, Sarah ;
Kirwan, Peter D. ;
Shrotri, Madhumita ;
Vusirikala, Amoolya ;
Rokadiya, Sakib ;
Kall, Meaghan ;
Zambon, Maria ;
Ramsay, Mary ;
Brooks, Tim ;
Brown, Colin S. ;
Chand, Meera A. ;
Hopkins, Susan .
LANCET, 2021, 397 (10283) :1459-1469
[5]   Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission [J].
Kim, Young-Il ;
Kim, Se-Mi ;
Park, Su-Jin ;
Kim, Eun-Ha ;
Yu, Kwang-Min ;
Chang, Jae-Hyung ;
Kim, Eun Ji ;
Casel, Mark Anthony B. ;
Rollon, Rare ;
Jang, Seung-Gyu ;
Um, Jihye ;
Song, Min-Suk ;
Jeong, Hye Won ;
Kim, Eung-Gook ;
Kim, Yeonjae ;
Kim, So Yeon ;
Park, Jun-Sun ;
Park, Mi Sun ;
Kwon, Geun-Yong ;
Yeo, Sang Gu ;
Lee, Shin-Ae ;
Choi, Youn Jung ;
Jung, Jae U. ;
Choi, Young Ki .
EMERGING MICROBES & INFECTIONS, 2021, 10 (01) :152-160
[6]   Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers [J].
Lumley, S. F. ;
O'Donnell, D. ;
Stoesser, N. E. ;
Matthews, P. C. ;
Howarth, A. ;
Hatch, S. B. ;
Marsden, B. D. ;
Cox, S. ;
James, T. ;
Warren, F. ;
Peck, L. J. ;
Ritter, T. G. ;
de Toledo, Z. ;
Warren, L. ;
Axten, D. ;
Cornall, R. J. ;
Jones, E. Y. ;
Stuart, D. I. ;
Screaton, G. ;
Ebner, D. ;
Hoosdally, S. ;
Chand, M. ;
Crook, D. W. ;
O'Donnell, A. -M. ;
Conlon, C. P. ;
Pouwels, K. B. ;
Walker, A. S. ;
Peto, T. E. A. ;
Hopkins, S. ;
Walker, T. M. ;
Jeffery, K. ;
Eyre, D. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06) :533-540
[7]   Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients [J].
Muecksch, Frauke ;
Wise, Helen ;
Batchelor, Becky ;
Squires, Maria ;
Semple, Elizabeth ;
Richardson, Claire ;
McGuire, Jacqueline ;
Clearly, Sarah ;
Furrie, Elizabeth ;
Greig, Neil ;
Hay, Gordon ;
Templeton, Kate ;
Lorenzi, Julio C. C. ;
Hatziioannou, Theodora ;
Jenks, Sara ;
Bieniasz, Paul D. .
JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (03) :389-398
[8]   Quantifying the risk of SARS-CoV-2 reinfection over time [J].
Murchu, Eamon O. ;
Byrne, Paula ;
Carty, Paul G. ;
De Gascun, Cillian ;
Keogan, Mary ;
O'Neill, Michelle ;
Harrington, Patricia ;
Ryan, Mairin .
REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (01)
[9]   Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals [J].
Ni, Ling ;
Ye, Fang ;
Cheng, Meng-Li ;
Feng, Yu ;
Deng, Yong-Qiang ;
Zhao, Hui ;
Wei, Peng ;
Ge, Jiwan ;
Gou, Mengting ;
Li, Xiaoli ;
Sun, Lin ;
Cao, Tianshu ;
Wang, Pengzhi ;
Zhou, Chao ;
Zhang, Rongrong ;
Liang, Peng ;
Guo, Han ;
Wang, Xinquan ;
Qin, Cheng-Feng ;
Chen, Fang ;
Dong, Chen .
IMMUNITY, 2020, 52 (06) :971-+
[10]   Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 [J].
Percivalle, Elena ;
Cambie, Giuseppe ;
Cassaniti, Irene ;
Nepita, Edoardo Vecchio ;
Maserati, Roberta ;
Ferrari, Alessandro ;
Di Martino, Raffaella ;
Isernia, Paola ;
Mojoli, Francesco ;
Bruno, Raffaele ;
Tirani, Marcello ;
Cereda, Danilo ;
Nicora, Carlo ;
Lombardo, Massimo ;
Baldanti, Fausto .
EUROSURVEILLANCE, 2020, 25 (24) :7-11